Skin manifestations of suspected COVID-19: Complications of the disease or reactivation of latent viral infections?

• Mariko Sugawara-Mikami, MD, PhD,
• Norihisa Ishii, MD, PhD,
• Masashi Yamazaki, MD, PhD,
• Takeshi Kambara, MD, PhD,
• Hiroaki Sasaki, MD,
• Natsuo Tachikawa, MD, PhD,
• Rie Yotsu, MD, PhD

Affiliations

Mariko Sugawara-Mikami, MD, PhD

West Yokohama Sugawara Dermatology Clinic, Kanagawa, Japan; Department of Dermatology, Tokyo Women's Medical University, Tokyo, Japan; Department of Clinical Laboratory Science, Faculty of Medical Technology, Teikyo University, Tokyo, Japan; Department of Dermatology, Yokohama City University, Kanagawa, Japan; Correspondence to: Mariko Sugawara-Mikami, MD, PhD, West Yokohama Sugawara Dermatology Clinic, 2-24-1 Tanikawa-Build, 3F, Tsuruya-cho Kanagawa-ku, Yokohama, Kanagawa 221-0835, Japan.

Norihisa Ishii, MD, PhD

National Sanatorium Tama Zenshoen, Tokyo, Japan

Masashi Yamazaki, MD, PhD

National Sanatorium Tama Zenshoen, Tokyo, Japan

Takeshi Kambara, MD, PhD

Department of Dermatology, Yokohama Municipal Citizen's Hospital, Kanagawa, Japan

Hiroaki Sasaki, MD

Department of Infectious Diseases, Yokohama Municipal Citizen's Hospital, Kanagawa, Japan

Natsuo Tachikawa, MD, PhD

Department of Infectious Diseases, Yokohama Municipal Citizen's Hospital, Kanagawa, Japan

Rie Yotsu, MD, PhD

Department of Tropical Medicine, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana; School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan; Department of Dermatology, National Center for Global Health and Medicine, Tokyo, Japan